Abstract:Coronary artery disease caused by atherosclerosis is the leading cause of morbidity and mortality in the world. Calcification of atherosclerotic plaque has predictive value in terms of cardiovascular event risk and mortality. The composition of calcium within plaque ( i.e. increased calcium density) has been associated with reduced vulnerability for cardiac events. Therapeutic modulation of atherosclerotic plaque calcium composition may have tremendous potential in terms of reducing event risk. HMG-CoA reductase inhibitors (statins) are a well-established family of medications that reduce the risk of myocardial infarction and are associated with increased plaque calcification, yet the underlying mechanisms of these processes are not well understood. Moreover, statin use can be associated with significant adverse reactions ( i.e. myalgias and new onset diabetes). Our group has identified a Rac-dependent inflammatory pathway that promotes IL-1β-driven atherosclerotic calcification. Using an atherosclerotic-prone mouse model, we found that progressive calcification of atherosclerotic plaque depends on altered Rac signaling and consequent IL-1β expression. Statin-treated primary macrophages expressed higher IL-1β mRNA and secreted more IL-1β protein in response to inflammasome activation by TLR-coupled cholesterol crystal phagocytosis. This statin-induced augmentation of IL-1β production depended on Rac1, as small molecule inhibition of Rac1 and Rac1 gene-deletion abrogated this effect. Statin treatment disrupted the association of Rac1 with its native inhibitor, Rho-GDI, through loss of Rac1 isoprenylation, and as a consequence, statin-treated macrophages demonstrated higher levels of GTP-bound Rac1. This higher activation of Rac1 led to increased NF-κB activation and consequent macrophage IL-1β mRNA expression. ApoE -/- mice placed on high fat diet with statin therapy revealed increases in aortic plaque calcification relative to control mice in association with altered serum IL-1β levels. Defining Rac signaling as a key mediator of statin-dependent mechanisms that modulate plaque calcium composition and consequent plaque stability may lead to novel therapeutic strategies for the prevention of cardiovascular events.

Statin'S Excitoprotection Is Mediated By Sapp And The Subsequent Attenuation Of Calpain-Induced Truncation Events, Likely Via Rho-Rock Signaling

Simvastatin exerts neuroprotective effects post-stroke by ameliorating endoplasmic reticulum stress and regulating autophagy/apoptosis balance through pAMPK/LC3B/ LAMP2 axis

Protection against the Neurotoxic Effects of β-Amyloid Peptide on Cultured Neuronal Cells by Lovastatin Involves Elevated Expression of α7 Nicotinic Acetylcholine Receptors and Activating Phosphorylation of Protein Kinases.

Statins: Multiple Neuroprotective Mechanisms in Neurodegenerative Diseases

Simvastatin Pretreatment Protects Cerebrum from Neuronal Injury by Decreasing the Expressions of Phosphor-CaMK II and AQP4 in Ischemic Stroke Rats

Statin-mediated protective effects in the central nervous system: General mechanisms and putative role of stress proteins

Apoptosis induced by simvastatin in rat vascular smooth muscle cell through Ca2+-calpain and caspase-3 dependent pathway.

Protective Effects of Statins Involving Both Enos and Tpa in Focal Cerebral Ischemia.

Abstract 650: Statins Modulate Rac-dependent IL-1 Beta Expression to Influence Calcium Composition

Neuroprotective Mechanisms Of Statins In Neurodegenerative Diseases

Upregulation of Protein Phosphatase 2a and Nr3a-Pleiotropic Effect of Simvastatin on Ischemic Stroke Rats

HMG-CoA Reductase Inhibitors Attenuate Neuronal Damage by Suppressing Oxygen Glucose Deprivation-Induced Activated Microglial Cells

Apoptosis Induced by Simvastatin in Rat Vascular Smooth Muscle Cells Through Calpain and Caspase-3-dependent Pathways

Effects of statins on α7 nicotinic receptor, cholinesterase and α-form of secreted amyloid precursor peptide in SH-SY5Y cells

Attenuation by Statins of Membrane Raft-Redox Signaling in Coronary Arterial Endothelium.

Simvastatin induces neuroprotection in 6-OHDA-lesioned PC12 via the PI3K/AKT/caspase 3 pathway and anti-inflammatory responses.

Statins decrease dendritic arborization in rat sympathetic neurons by blocking RhoA activation

Lovastatin Suppresses the Aberrant Tau Phosphorylation from FTDP-17 Mutation and Okadaic Acid-Induction in Rat Primary Neurons

Statins promote the growth of experimentally induced cerebral aneurysms in estrogen-deficient rats

Resveratrol Inhibits Β-Amyloid-induced Neuronal Apoptosis Through Regulation of SIRT1-ROCK1 Signaling Pathway.

Simvastatin inhibits neural cell apoptosis and promotes locomotor recovery via activation of Wnt/β‐catenin signaling pathway after spinal cord injury